Press Releases

Recro Reports Financial Results for the Year Ended 2019

Mar 04, 2020 7:00am EST

Recro to Report Year End 2019 Financial Results and Host Conference Call and Webcast on March 4, 2020

Mar 02, 2020 7:00am EST

Recro Completes Separation of Baudax Bio and Becomes a Dedicated Contract Development and Manufacturing Organization

Nov 21, 2019 4:30pm EST

Baudax Bio™ Launches as a New Pharmaceutical Company Aimed at Advancing Promising, Non-Opioid Analgesic Therapies

Nov 21, 2019 7:00am EST

Recro Pharma Announces Effectiveness of Baudax Bio Form 10 Registration Statement

Nov 13, 2019 7:00am EST

Recro Pharma Reports Third Quarter 2019 Financial Results

Nov 08, 2019 7:00am EST

Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019

Nov 05, 2019 4:05pm EST

Recro Pharma’s Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio Common Stock

Nov 05, 2019 7:00am EST

FDA Grants Appeal to Recro Pharma for IV Meloxicam New Drug Application

Oct 31, 2019 7:00am EDT

Recro Pharma Reports Second Quarter 2019 Financial Results

Aug 08, 2019 7:14am EDT

1
2
3
4
5
6
7
8
9
10
...17